IRF1 and neoplasm: NR4A1 was markedly upregulated in tumor-infiltrating NK cells, which reduced the efficacy of anti-PD-1 therapy through modulation of the IFN-γ/p-STAT1/IRF1 signaling pathway, leading to dysfunctional tumor-infiltrating NK cells [103].